Nigerian arrested for smuggling Hepatitis B medications at Aflao Border

The suspect, identified as Obinna Robinson, was arrested on Tuesday, March 11, at approximately 9:00 AM upon arrival. Authorities conducting routine inspections discovered 1,200 ampoules of Euvax B, Eupenta injection, and Hepatitis B vaccine rDNA hidden within the structural compartments of a Sienna vehicle.

Is allowance instantly strangers applauded

A 35-year-old Nigerian man has been apprehended by a multi-agency security team at the Aflao Border for allegedly attempting to smuggle a significant quantity of Hepatitis B medication into Ghana.

The suspect, identified as Obinna Robinson, was arrested on Tuesday, March 11, at approximately 9:00 AM upon arrival. Authorities conducting routine inspections discovered 1,200 ampoules of Euvax B, Eupenta injection, and Hepatitis B vaccine rDNA hidden within the structural compartments of a Sienna vehicle. The vehicle, bearing registration number ENU 369 ZG, belongs to Amadel Transport Company, Nigeria.

The discovery was made during a coordinated security operation involving officers from the Food and Drugs Authority (FDA), the Narcotics Control Commission, the Customs Division of the Ghana Revenue Authority, the Small Arms and Light Weapons Commission, and other security agencies.

Following the arrest, officials seized both the medication and the vehicle, launching further investigations into the smuggling attempt.

During a media briefing with the Ghana News Agency, Volta Regional Head of the FDA, Mr. Gordon Akurugu, reiterated the agency’s commitment to tightening security at inland borders to prevent illegal drug trafficking.

He emphasized that pharmaceuticals are legally required to enter the country only through designated air and sea entry points, such as Kotoka International Airport and Ghana’s harbors.

He further warned that such unauthorized smuggling poses a significant public health risk, as improperly stored vaccines could negatively impact patients who rely on them.

Mr. Akurugu urged regulatory bodies in Nigeria to strengthen their oversight of pharmaceutical exports to ensure compliance with international health and safety standards.